pdf,description,instructions,promt,output
45_1-s2.0-S1876034121003282-main.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Au"",""Bacteria"":""Bacillus subtilis"",""ATCC_species"":""MTCC 2394"",""NP_Synthesis"":""Panchagavya mediated synthesis"",""Drug"":""Ciprofloxacin"",""Drug_dose"":""10 µL"",""NP_concentration"":""40 µL"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""53.29""},""shape"":""spherical"",""method"":""well_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""12.33"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.17"",""ZOI_NP_or_MC_NP"":""11.42"",""error_ZOI_NP_or_MC_NP"":""0.58"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""-9.8"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Au"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""MTCC 448"",""NP_Synthesis"":""Panchagavya mediated synthesis"",""Drug"":""Ciprofloxacin"",""Drug_dose"":""10 µL"",""NP_concentration"":""40 µL"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""53.29""},""shape"":""spherical"",""method"":""well_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""14.33"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.53"",""ZOI_NP_or_MC_NP"":""12.67"",""error_ZOI_NP_or_MC_NP"":""0.24"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""-9.8"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Au"",""Bacteria"":""Klebsiella pneumoniae"",""ATCC_species"":""MTCC 109"",""NP_Synthesis"":""Panchagavya mediated synthesis"",""Drug"":""Ciprofloxacin"",""Drug_dose"":""10 µL"",""NP_concentration"":""40 µL"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""53.29""},""shape"":""spherical"",""method"":""well_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""26.0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.57"",""ZOI_NP_or_MC_NP"":""17.12"",""error_ZOI_NP_or_MC_NP"":""0.14"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""-9.8"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
11_fbioe-09-652362.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""An-AgNPs"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Green synthesis using Anastatica hierochuntica"",""Drug"":""Bacitracin"",""Drug_dose"":""10 µg/mL"",""NP_concentration"":""1 mg/mL"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""114""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""6"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""23.6"",""error_ZOI_NP_or_MC_NP"":""3.8"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""Substantial"",""Zeta_potential_mV"":""-1.2"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""An-AgNPs"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Green synthesis using Anastatica hierochuntica"",""Drug"":""Ciprofloxacin"",""Drug_dose"":""10 µg/mL"",""NP_concentration"":""1 mg/mL"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""114""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""7"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""22.4"",""error_ZOI_NP_or_MC_NP"":""0.4"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""Slight"",""Zeta_potential_mV"":""-1.2"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ar-AgNPs"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Green synthesis using Artemisia absinthium"",""Drug"":""Cefixime"",""Drug_dose"":""5 µg/mL"",""NP_concentration"":""1 mg/mL"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""125.5""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""6"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""24.7"",""error_ZOI_NP_or_MC_NP"":""0.3"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""Significant"",""Zeta_potential_mV"":""-0.4"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
41_li2014.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""AuNP"",""Bacteria"":""E. coli"",""ATCC_species"":""CD-2"",""NP_Synthesis"":""cationic synthesis"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""16 nM"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""2""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""16 nM"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""No"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""AuNP"",""Bacteria"":""P. aeruginosa"",""ATCC_species"":""CD-1006"",""NP_Synthesis"":""cationic synthesis"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""16 nM"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""2""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""16 nM"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""No"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""AuNP"",""Bacteria"":""S. aureus (MRSA)"",""ATCC_species"":""CD-489"",""NP_Synthesis"":""cationic synthesis"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""32 nM"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""2""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""32 nM"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""Yes"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
53_burygin2009.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Gold"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""K12"",""NP_Synthesis"":""Not specified"",""Drug"":""Gentamicin"",""Drug_dose"":""Not specified"",""NP_concentration"":""Not specified"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""16.0""},""shape"":""Not specified"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""7.4"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""7.4"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""7.4"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""No significant effect"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
78_priyanka2016.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""TiO2"",""Bacteria"":""Streptococcus pneumonia"",""ATCC_species"":""MTCC 2672"",""NP_Synthesis"":""sol–gel method"",""Drug"":""Tetracycline"",""Drug_dose"":""30 μl/disc"",""NP_concentration"":""250 μg/ml"",""sizes"":{""min_nm"":""6"",""max_nm"":""25.8"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""3.5 cm"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""3.4 cm"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""12-24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""TiO2"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""MTCC 96"",""NP_Synthesis"":""sol–gel method"",""Drug"":""Tetracycline"",""Drug_dose"":""30 μl/disc"",""NP_concentration"":""250 μg/ml"",""sizes"":{""min_nm"":""6"",""max_nm"":""25.8"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""3.1 cm"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""3.2 cm"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""12-24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""TiO2"",""Bacteria"":""Proteus vulgaris"",""ATCC_species"":""MTCC 1771"",""NP_Synthesis"":""sol–gel method"",""Drug"":""Tetracycline"",""Drug_dose"":""30 μl/disc"",""NP_concentration"":""250 μg/ml"",""sizes"":{""min_nm"":""6"",""max_nm"":""25.8"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""2.1 cm"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""1.6 cm"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""12-24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""TiO2"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""MTCC 424"",""NP_Synthesis"":""sol–gel method"",""Drug"":""Tetracycline"",""Drug_dose"":""30 μl/disc"",""NP_concentration"":""250 μg/ml"",""sizes"":{""min_nm"":""6"",""max_nm"":""25.8"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""2.1 cm"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""2.4 cm"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""12-24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""TiO2"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""MTCC 443"",""NP_Synthesis"":""sol–gel method"",""Drug"":""Tetracycline"",""Drug_dose"":""30 μl/disc"",""NP_concentration"":""250 μg/ml"",""sizes"":{""min_nm"":""6"",""max_nm"":""25.8"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""2.3 cm"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""2.3 cm"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""12-24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
57_2634_pdf.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Au"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Biosynthesis using Pleurotus ostreatus"",""Drug"":""Azithromycin"",""Drug_dose"":""15 μg/disc"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""10"",""max_nm"":""30"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""25"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""36"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""1-2"",""Zeta_potential_mV"":""-24.0"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Au"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Biosynthesis using Pleurotus ostreatus"",""Drug"":""Levofloxacin"",""Drug_dose"":""5 μg/disc"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""10"",""max_nm"":""30"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""25"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""36"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""1-2"",""Zeta_potential_mV"":""-24.0"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Au"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Biosynthesis using Pleurotus ostreatus"",""Drug"":""Amoxicillin"",""Drug_dose"":""25 μg/disc"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""10"",""max_nm"":""30"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""17"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""27"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""1-2"",""Zeta_potential_mV"":""-24.0"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
3_antibiotics-11-01205-v2.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""AgNPs"",""Bacteria"":""Klebsiella pneumoniae"",""ATCC_species"":""ATCC 25922"",""NP_Synthesis"":""Autoclaved synthesis"",""Drug"":""Ampicillin"",""Drug_dose"":""12.5"",""NP_concentration"":""50"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""15""},""shape"":""Spherical"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""12.5"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""12.5"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""6.25"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""AgNPs"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""BJ915"",""NP_Synthesis"":""NaBH4 reduction"",""Drug"":""Gentamicin"",""Drug_dose"":""16"",""NP_concentration"":""32"",""sizes"":{""min_nm"":""2"",""max_nm"":""25"",""avg_nm"":""15""},""shape"":""Cubic"",""method"":""MBC"",""ZOI_drug_mm_or_Minimal_concentration"":""6.4"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""12"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""4"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""23"",""viability_error"":""NaN""}]}"
77_catalysts-12-00181-v3.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Biosynthesized TiO2"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""ATCC 25922"",""NP_Synthesis"":""Green Synthesis using A. calamus leaf extract"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""10 µg/mL"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""15-40""},""shape"":""Globular"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""9 ± 0.3"",""error_ZOI_NP_or_MC_NP"":""0.3"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Biosynthesized TiO2"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""ATCC 27853"",""NP_Synthesis"":""Green Synthesis using A. calamus leaf extract"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""10 µg/mL"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""15-40""},""shape"":""Globular"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""6 ± 0.2"",""error_ZOI_NP_or_MC_NP"":""0.2"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Biosynthesized TiO2"",""Bacteria"":""Bacillus subtilis"",""ATCC_species"":""ATCC 6633"",""NP_Synthesis"":""Green Synthesis using A. calamus leaf extract"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""10 µg/mL"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""15-40""},""shape"":""Globular"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""12 ± 0.4"",""error_ZOI_NP_or_MC_NP"":""0.4"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Biosynthesized TiO2"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""ATCC 25923"",""NP_Synthesis"":""Green Synthesis using A. calamus leaf extract"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""10 µg/mL"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""15-40""},""shape"":""Globular"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""10 ± 0.3"",""error_ZOI_NP_or_MC_NP"":""0.3"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
55_8f8eba2a8c57f32465306f7e987d8050.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""CS-AuNP"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Biosynthesis using Lignosus rhinocerotis and chitosan"",""Drug"":""Gentamicin"",""Drug_dose"":""0.1 mg/mL"",""NP_concentration"":""0.05"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""82.4""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""22.3"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.1"",""ZOI_NP_or_MC_NP"":""12.9"",""error_ZOI_NP_or_MC_NP"":""0.3"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""+30.8"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""CS-AuNP"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Biosynthesis using Lignosus rhinocerotis and chitosan"",""Drug"":""Gentamicin"",""Drug_dose"":""0.1 mg/mL"",""NP_concentration"":""0.05"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""82.4""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""20.3"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.0"",""ZOI_NP_or_MC_NP"":""15.2"",""error_ZOI_NP_or_MC_NP"":""0.8"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
29_10.3390@polym13040659.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Ag"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""PTCC1431"",""NP_Synthesis"":""NaN"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""4 µg/mL"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""10""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""4"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""ZnO"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""29213"",""NP_Synthesis"":""NaN"",""Drug"":""Gentamicin sulphate"",""Drug_dose"":""10 µg/mL"",""NP_concentration"":""21%"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""100""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""37"",""error_ZOI_drug_mm_or_Minimal_concentration"":""2"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""TiO2"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""29213"",""NP_Synthesis"":""NaN"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""33%"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""100""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
22_lambio0680.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Silver nanoparticles"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""ATCC 27853"",""NP_Synthesis"":""Biological synthesis using Aspergillus flavus"",""Drug"":""Levofloxacin"",""Drug_dose"":""NaN"",""NP_concentration"":""F-NP 0.5 mg/mL, L-NP 6.5 mg/mL"",""sizes"":{""min_nm"":""5.34"",""max_nm"":""70"",""avg_nm"":""26.06""},""shape"":""spherical"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""4-128 μg/mL (F-NP), 8->128 μg/mL (L-NP)"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""Significant reduction with F-NP"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""Yes"",""FIC"":""NaN"",""Effect"":""Synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
13_pompilio2018.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""AgNPs"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""Pa14"",""NP_Synthesis"":""Electrochemical synthesis"",""Drug"":""Tobramycin"",""Drug_dose"":""4"",""NP_concentration"":""34.1"",""sizes"":{""min_nm"":""26.3"",""max_nm"":""81.7"",""avg_nm"":""55.6""},""shape"":""quasi-spherical"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""1"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""1.06"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""-51.5 ± 2.5"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""Comparable"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""AgNPs"",""Bacteria"":""Burkholderia cepacia"",""ATCC_species"":""Bc23"",""NP_Synthesis"":""Electrochemical synthesis"",""Drug"":""Tobramycin"",""Drug_dose"":""NaN"",""NP_concentration"":""34.1"",""sizes"":{""min_nm"":""26.3"",""max_nm"":""81.7"",""avg_nm"":""55.6""},""shape"":""quasi-spherical"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":"">256"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""1.06"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""-51.5 ± 2.5"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""Higher than drug alone"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""AgNPs"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""Sa1"",""NP_Synthesis"":""Electrochemical synthesis"",""Drug"":""Tobramycin"",""Drug_dose"":""NaN"",""NP_concentration"":""34.1"",""sizes"":{""min_nm"":""26.3"",""max_nm"":""81.7"",""avg_nm"":""55.6""},""shape"":""quasi-spherical"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""NT"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""8.5"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""-51.5 ± 2.5"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""Comparable"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
66_1-s2.0-S2590123022001207-main.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Fe2O3"",""Bacteria"":""Klebsiella pneumoniae"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Achyranthes Aspera mediated green synthesis"",""Drug"":""No drug used"",""Drug_dose"":""NaN"",""NP_concentration"":""50 mg/mL"",""sizes"":{""min_nm"":""20"",""max_nm"":""40"",""avg_nm"":""30""},""shape"":""Spherical"",""method"":""Well diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""21"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""12-14"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Fe2O3"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Achyranthes Aspera mediated green synthesis"",""Drug"":""No drug used"",""Drug_dose"":""NaN"",""NP_concentration"":""50 mg/mL"",""sizes"":{""min_nm"":""20"",""max_nm"":""40"",""avg_nm"":""30""},""shape"":""Spherical"",""method"":""Well diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""15"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""12-14"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Fe2O3"",""Bacteria"":""Bacillus"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Achyranthes Aspera mediated green synthesis"",""Drug"":""No drug used"",""Drug_dose"":""NaN"",""NP_concentration"":""50 mg/mL"",""sizes"":{""min_nm"":""20"",""max_nm"":""40"",""avg_nm"":""30""},""shape"":""Spherical"",""method"":""Well diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""18"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""12-14"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
71_jfb-13-00138.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Fe3O4"",""Bacteria"":""Staphylococcus epidermidis"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Co-precipitation method, PEG coating"",""Drug"":""Gentamicin"",""Drug_dose"":""NaN"",""NP_concentration"":""50"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""35""},""shape"":""NaN"",""method"":""Disc diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""21.33"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.57"",""ZOI_NP_or_MC_NP"":""17.6"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""23.6"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""50"",""peptide_MIC"":""25"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Fe3O4"",""Bacteria"":""Proteus mirabilis"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Co-precipitation method, PEG coating"",""Drug"":""Gentamicin"",""Drug_dose"":""NaN"",""NP_concentration"":""50"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""35""},""shape"":""NaN"",""method"":""Disc diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""22.66"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.57"",""ZOI_NP_or_MC_NP"":""18.6"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""23.6"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""50"",""peptide_MIC"":""25"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Fe3O4"",""Bacteria"":""Acinetobacter baumannii"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Co-precipitation method, PEG coating"",""Drug"":""Gentamicin"",""Drug_dose"":""NaN"",""NP_concentration"":""50"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""35""},""shape"":""NaN"",""method"":""Disc diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""20.33"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.57"",""ZOI_NP_or_MC_NP"":""20.3"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""26.33"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""50"",""peptide_MIC"":""50"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
91_crystals-12-01513-v3.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""ZnO"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""ATCC 25922"",""NP_Synthesis"":""Green synthesis using water extract of Origanum majorana"",""Drug"":""Colistin"",""Drug_dose"":""10 µg/Disk"",""NP_concentration"":""15 µg/Disk"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""12.467""},""shape"":""NaN"",""method"":""disc diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""17.89"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.18"",""ZOI_NP_or_MC_NP"":""16.95"",""error_ZOI_NP_or_MC_NP"":""0.38"",""ZOI_drug_NP_or_MIC_drug_NP"":""34.18"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.25"",""fold_increase_in_antibacterial_activity"":""91.05%"",""Zeta_potential_mV"":""-14.8"",""MDR"":""R"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""ZnO"",""Bacteria"":""Acinetobacter baumannii"",""ATCC_species"":""ATCC 43498"",""NP_Synthesis"":""Green synthesis using water extract of Origanum majorana"",""Drug"":""Colistin"",""Drug_dose"":""10 µg/Disk"",""NP_concentration"":""15 µg/Disk"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""12.467""},""shape"":""NaN"",""method"":""disc diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""11.78"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.23"",""ZOI_NP_or_MC_NP"":""10.35"",""error_ZOI_NP_or_MC_NP"":""0.11"",""ZOI_drug_NP_or_MIC_drug_NP"":""20.62"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.14"",""fold_increase_in_antibacterial_activity"":""75.04%"",""Zeta_potential_mV"":""-14.8"",""MDR"":""R"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""ZnO"",""Bacteria"":""Klebsiella pneumoniae"",""ATCC_species"":""ATCC 700603"",""NP_Synthesis"":""Green synthesis using water extract of Origanum majorana"",""Drug"":""Colistin"",""Drug_dose"":""10 µg/Disk"",""NP_concentration"":""15 µg/Disk"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""12.467""},""shape"":""NaN"",""method"":""disc diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""15.29"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.09"",""ZOI_NP_or_MC_NP"":""16.84"",""error_ZOI_NP_or_MC_NP"":""0.24"",""ZOI_drug_NP_or_MIC_drug_NP"":""27.38"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.41"",""fold_increase_in_antibacterial_activity"":""79.07%"",""Zeta_potential_mV"":""-14.8"",""MDR"":""R"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""ZnO"",""Bacteria"":""Salmonella typhimurium"",""ATCC_species"":""ATCC 14023"",""NP_Synthesis"":""Green synthesis using water extract of Origanum majorana"",""Drug"":""Colistin"",""Drug_dose"":""10 µg/Disk"",""NP_concentration"":""15 µg/Disk"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""12.467""},""shape"":""NaN"",""method"":""disc diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""13.78"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.51"",""ZOI_NP_or_MC_NP"":""14.97"",""error_ZOI_NP_or_MC_NP"":""0.43"",""ZOI_drug_NP_or_MIC_drug_NP"":""24.15"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.17"",""fold_increase_in_antibacterial_activity"":""75.25%"",""Zeta_potential_mV"":""-14.8"",""MDR"":""R"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""ZnO"",""Bacteria"":""Enterobacter cloacae"",""ATCC_species"":""ATCC 13047"",""NP_Synthesis"":""Green synthesis using water extract of Origanum majorana"",""Drug"":""Colistin"",""Drug_dose"":""10 µg/Disk"",""NP_concentration"":""15 µg/Disk"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""12.467""},""shape"":""NaN"",""method"":""disc diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""14.16"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.56"",""ZOI_NP_or_MC_NP"":""15.18"",""error_ZOI_NP_or_MC_NP"":""0.49"",""ZOI_drug_NP_or_MIC_drug_NP"":""22.13"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.32"",""fold_increase_in_antibacterial_activity"":""56.28%"",""Zeta_potential_mV"":""-14.8"",""MDR"":""R"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""ZnO"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""ATCC 9027"",""NP_Synthesis"":""Green synthesis using water extract of Origanum majorana"",""Drug"":""Colistin"",""Drug_dose"":""10 µg/Disk"",""NP_concentration"":""15 µg/Disk"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""12.467""},""shape"":""NaN"",""method"":""disc diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""14.89"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.16"",""ZOI_NP_or_MC_NP"":""8.98"",""error_ZOI_NP_or_MC_NP"":""0.12"",""ZOI_drug_NP_or_MIC_drug_NP"":""16.42"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.46"",""fold_increase_in_antibacterial_activity"":""10.60%"",""Zeta_potential_mV"":""-14.8"",""MDR"":""R"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
14_fmicb-12-750556.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Ag"",""Bacteria"":""E. coli ML-35p"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Gelatin coating"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""24"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""6"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""12"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""4-fold reduction"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""PG-1"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""S. aureus ATCC 25923"",""ATCC_species"":""ATCC 25923"",""NP_Synthesis"":""Gelatin coating"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""12"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""12"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""6"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""Not reported"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""Lysozyme"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""P. aeruginosa ATCC 27853"",""ATCC_species"":""ATCC 27853"",""NP_Synthesis"":""Gelatin coating"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""24"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""6"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""12"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""4-fold reduction"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""PG-1"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""S. aureus 1399/17 clin.is."",""ATCC_species"":""1399/17 clin.is."",""NP_Synthesis"":""Gelatin coating"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""48"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""6"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""12"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""4-fold reduction"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""Lysozyme"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""MRSA ATCC 33591"",""ATCC_species"":""ATCC 33591"",""NP_Synthesis"":""Gelatin coating"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""48"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""6"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""12"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""4-fold reduction"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""Lysozyme"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
4_antibiotics-11-01219-v2.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Ag"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""ATCC 25922"",""NP_Synthesis"":""purchased from US Research Nanomaterials, Inc."",""Drug"":""Ampicillin"",""Drug_dose"":""2"",""NP_concentration"":""64"",""sizes"":{""min_nm"":""15"",""max_nm"":""25"",""avg_nm"":""20""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""2"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""64"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""32"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""1"",""Effect"":""Indifference"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""ATCC 25922"",""NP_Synthesis"":""purchased from US Research Nanomaterials, Inc."",""Drug"":""Kanamycin"",""Drug_dose"":""2"",""NP_concentration"":""64"",""sizes"":{""min_nm"":""15"",""max_nm"":""25"",""avg_nm"":""20""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""2"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""16"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""4"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""0.1"",""Effect"":""Synergism"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""ATCC 25922"",""NP_Synthesis"":""purchased from US Research Nanomaterials, Inc."",""Drug"":""Colistin"",""Drug_dose"":""2"",""NP_concentration"":""128"",""sizes"":{""min_nm"":""15"",""max_nm"":""25"",""avg_nm"":""20""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""2"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""32"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""4"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""0.1"",""Effect"":""Synergism"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""ATCC 25922"",""NP_Synthesis"":""purchased from US Research Nanomaterials, Inc."",""Drug"":""Rifampicin"",""Drug_dose"":""4"",""NP_concentration"":""128"",""sizes"":{""min_nm"":""15"",""max_nm"":""25"",""avg_nm"":""20""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""4"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""16"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""16"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""0.2"",""Effect"":""Synergism"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""ATCC 25922"",""NP_Synthesis"":""purchased from US Research Nanomaterials, Inc."",""Drug"":""Vancomycin"",""Drug_dose"":""256"",""NP_concentration"":""128"",""sizes"":{""min_nm"":""15"",""max_nm"":""25"",""avg_nm"":""20""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""512"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""32"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""16"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""0.5"",""Effect"":""Synergism"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
74_grumezescu2014.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Fe3O4@AMO"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""ATCC 29213"",""NP_Synthesis"":""Covalent bonding"",""Drug"":""Amoxicillin"",""Drug_dose"":""NaN"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""10.0""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""3-fold"",""Zeta_potential_mV"":""70"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Fe3O4@AMO"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""ATCC 25922"",""NP_Synthesis"":""Covalent bonding"",""Drug"":""Amoxicillin"",""Drug_dose"":""NaN"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""10.0""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""4-fold"",""Zeta_potential_mV"":""70"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
70_10.1016@j.dib.2019.104929.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Fe3O4"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Malva sylvestris"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""250"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""250"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""125"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Fe3O4"",""Bacteria"":""Corynebacterium"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Malva sylvestris"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""500"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""1000"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""62.5"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Fe3O4"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Malva sylvestris"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""250"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""500"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""125"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Fe3O4"",""Bacteria"":""Klebsiella pneumoniae"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Malva sylvestris"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""500"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""500"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""125"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
63_pallela2019.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""α-Fe2O3"",""Bacteria"":""Bacillus subtilis"",""ATCC_species"":""NCIM-2063"",""NP_Synthesis"":""Green synthesis using Sida cordifolia extract"",""Drug"":""Neomycin"",""Drug_dose"":""50 μg/mL"",""NP_concentration"":""50 μg/mL"",""sizes"":{""min_nm"":""10"",""max_nm"":""22"",""avg_nm"":""16""},""shape"":""asymmetric"",""method"":""Agar well diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""17"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""16.00"",""error_ZOI_NP_or_MC_NP"":""1.00"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""α-Fe2O3"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""NCIM-2079"",""NP_Synthesis"":""Green synthesis using Sida cordifolia extract"",""Drug"":""Neomycin"",""Drug_dose"":""50 μg/mL"",""NP_concentration"":""50 μg/mL"",""sizes"":{""min_nm"":""10"",""max_nm"":""22"",""avg_nm"":""16""},""shape"":""asymmetric"",""method"":""Agar well diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""15"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""13.67"",""error_ZOI_NP_or_MC_NP"":""0.58"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""α-Fe2O3"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""NCIM-2065"",""NP_Synthesis"":""Green synthesis using Sida cordifolia extract"",""Drug"":""Neomycin"",""Drug_dose"":""50 μg/mL"",""NP_concentration"":""50 μg/mL"",""sizes"":{""min_nm"":""10"",""max_nm"":""22"",""avg_nm"":""16""},""shape"":""asymmetric"",""method"":""Agar well diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""15"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""11.33"",""error_ZOI_NP_or_MC_NP"":""0.58"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""α-Fe2O3"",""Bacteria"":""Klebsiella pneumonia"",""ATCC_species"":""NCIM-2327"",""NP_Synthesis"":""Green synthesis using Sida cordifolia extract"",""Drug"":""Neomycin"",""Drug_dose"":""50 μg/mL"",""NP_concentration"":""50 μg/mL"",""sizes"":{""min_nm"":""10"",""max_nm"":""22"",""avg_nm"":""16""},""shape"":""asymmetric"",""method"":""Agar well diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""19"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""12.00"",""error_ZOI_NP_or_MC_NP"":""1.00"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
33_s11274-017-2406-3.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Ag"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""ATCC 8739"",""NP_Synthesis"":""synthesized from Streptomyces xinghaiensis OF1"",""Drug"":""Ampicillin"",""Drug_dose"":""64"",""NP_concentration"":""4"",""sizes"":{""min_nm"":""5"",""max_nm"":""20"",""avg_nm"":""64""},""shape"":""spherical, polydispersed"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""> 1024"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""64"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""64 + 4"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""0.12"",""Zeta_potential_mV"":""-15.7"",""MDR"":""NaN"",""FIC"":""0.12"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""ATCC 10145"",""NP_Synthesis"":""synthesized from Streptomyces xinghaiensis OF1"",""Drug"":""Ampicillin"",""Drug_dose"":""768"",""NP_concentration"":""32"",""sizes"":{""min_nm"":""5"",""max_nm"":""20"",""avg_nm"":""64""},""shape"":""spherical, polydispersed"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""384"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""16"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""768 + 32"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""2.0"",""Zeta_potential_mV"":""-15.7"",""MDR"":""NaN"",""FIC"":""2.0"",""Effect"":""indifferent"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
2_ghafoori2017.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Ag"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""ATCC 66538"",""NP_Synthesis"":""biosynthesis using Cassia fistula fruit extract"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""50"",""max_nm"":""150"",""avg_nm"":""31.16""},""shape"":""triangular, hexahedral and amorphous"",""method"":""Agar well diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""14.76"",""error_ZOI_NP_or_MC_NP"":""0.88"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Acinetobacter baumannii"",""ATCC_species"":""ATCC 19606"",""NP_Synthesis"":""biosynthesis using Cassia fistula fruit extract"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""50"",""max_nm"":""150"",""avg_nm"":""31.16""},""shape"":""triangular, hexahedral and amorphous"",""method"":""Agar well diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""14.33"",""error_ZOI_NP_or_MC_NP"":""0.88"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""ATCC 27853"",""NP_Synthesis"":""biosynthesis using Cassia fistula fruit extract"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""50"",""max_nm"":""150"",""avg_nm"":""31.16""},""shape"":""triangular, hexahedral and amorphous"",""method"":""Agar well diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""16.33"",""error_ZOI_NP_or_MC_NP"":""0.88"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
24_swolana2020.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Ag"",""Bacteria"":""Staphylococcus epidermidis"",""ATCC_species"":""ATCC 35984"",""NP_Synthesis"":""purchased from Sigma-Aldrich/Merck"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""7.0"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""10.0""},""shape"":""NaN"",""method"":""Alamar Blue test"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24.0"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""0.0"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Staphylococcus epidermidis"",""ATCC_species"":""ATCC 12228"",""NP_Synthesis"":""purchased from Sigma-Aldrich/Merck"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""7.0"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""10.0""},""shape"":""NaN"",""method"":""Alamar Blue test"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24.0"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""0.0"",""viability_error"":""NaN""}]}"
12_patra2017.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Ag"",""Bacteria"":""Bacillus cereus"",""ATCC_species"":""ATCC 13061"",""NP_Synthesis"":""NaN"",""Drug"":""Kanamycin"",""Drug_dose"":""5"",""NP_concentration"":""25"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0.0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""11.39"",""error_ZOI_NP_or_MC_NP"":""1.2"",""ZOI_drug_NP_or_MIC_drug_NP"":""11.67"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.16"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""ATCC 43890"",""NP_Synthesis"":""NaN"",""Drug"":""Kanamycin"",""Drug_dose"":""5"",""NP_concentration"":""25"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0.0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""10.55"",""error_ZOI_NP_or_MC_NP"":""0.27"",""ZOI_drug_NP_or_MIC_drug_NP"":""12.45"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""2.02"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Listeria monocytogenes"",""ATCC_species"":""ATCC 19115"",""NP_Synthesis"":""NaN"",""Drug"":""Kanamycin"",""Drug_dose"":""5"",""NP_concentration"":""25"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0.0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""9.26"",""error_ZOI_NP_or_MC_NP"":""0.31"",""ZOI_drug_NP_or_MIC_drug_NP"":""10.62"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.29"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""ATCC 49444"",""NP_Synthesis"":""NaN"",""Drug"":""Kanamycin"",""Drug_dose"":""5"",""NP_concentration"":""25"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0.0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""11.57"",""error_ZOI_NP_or_MC_NP"":""0.25"",""ZOI_drug_NP_or_MIC_drug_NP"":""12.57"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.20"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Salmonella Typhimurium"",""ATCC_species"":""ATCC 43174"",""NP_Synthesis"":""NaN"",""Drug"":""Kanamycin"",""Drug_dose"":""5"",""NP_concentration"":""25"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0.0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""11.22"",""error_ZOI_NP_or_MC_NP"":""0.38"",""ZOI_drug_NP_or_MIC_drug_NP"":""12.80"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.31"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Bacillus cereus"",""ATCC_species"":""ATCC 13061"",""NP_Synthesis"":""NaN"",""Drug"":""Rifampicin"",""Drug_dose"":""5"",""NP_concentration"":""25"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0.0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""11.39"",""error_ZOI_NP_or_MC_NP"":""1.2"",""ZOI_drug_NP_or_MIC_drug_NP"":""12.76"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.44"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""ATCC 43890"",""NP_Synthesis"":""NaN"",""Drug"":""Rifampicin"",""Drug_dose"":""5"",""NP_concentration"":""25"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0.0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""10.55"",""error_ZOI_NP_or_MC_NP"":""0.27"",""ZOI_drug_NP_or_MIC_drug_NP"":""11.43"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.21"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Listeria monocytogenes"",""ATCC_species"":""ATCC 19115"",""NP_Synthesis"":""NaN"",""Drug"":""Rifampicin"",""Drug_dose"":""5"",""NP_concentration"":""25"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0.0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""9.26"",""error_ZOI_NP_or_MC_NP"":""0.31"",""ZOI_drug_NP_or_MIC_drug_NP"":""11.64"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.23"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""ATCC 49444"",""NP_Synthesis"":""NaN"",""Drug"":""Rifampicin"",""Drug_dose"":""5"",""NP_concentration"":""25"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0.0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""11.57"",""error_ZOI_NP_or_MC_NP"":""0.25"",""ZOI_drug_NP_or_MIC_drug_NP"":""14.33"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.40"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Salmonella Typhimurium"",""ATCC_species"":""ATCC 43174"",""NP_Synthesis"":""NaN"",""Drug"":""Rifampicin"",""Drug_dose"":""5"",""NP_concentration"":""25"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0.0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""11.22"",""error_ZOI_NP_or_MC_NP"":""0.38"",""ZOI_drug_NP_or_MIC_drug_NP"":""11.45"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.19"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
89_sharma2016.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""ZnO"",""Bacteria"":""Bacillus subtilis"",""ATCC_species"":""MTCC 736"",""NP_Synthesis"":""not specified"",""Drug"":""Ciprofloxacin"",""Drug_dose"":""NaN"",""NP_concentration"":""100 mg/ml"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""20""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""2-4"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""0.004"",""error_ZOI_NP_or_MC_NP"":""0.00"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""0.24"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""0.004"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""ZnO"",""Bacteria"":""Bacillus subtilis"",""ATCC_species"":""MTCC 736"",""NP_Synthesis"":""not specified"",""Drug"":""Ampicillin"",""Drug_dose"":""1-34 μg/ml"",""NP_concentration"":""100 mg/ml"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""20""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""1-34"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""0.004"",""error_ZOI_NP_or_MC_NP"":""0.00"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""0.27"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""0.004"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""ZnO"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""MTCC 739"",""NP_Synthesis"":""not specified"",""Drug"":""Ciprofloxacin"",""Drug_dose"":""NaN"",""NP_concentration"":""100 mg/ml"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""20""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""0.5-4"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""0.004"",""error_ZOI_NP_or_MC_NP"":""0.00"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""0.39"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""0.004"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
19_markowska2014.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""AgNPs"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""ATCC 10145"",""NP_Synthesis"":""non-explosive high-voltage method"",""Drug"":""Ampicillin"",""Drug_dose"":""16.0"",""NP_concentration"":""0.25"",""sizes"":{""min_nm"":""2"",""max_nm"":""35"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""chequerboard"",""ZOI_drug_mm_or_Minimal_concentration"":""256"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""1"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""0.3125"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""0.3125"",""Effect"":""Synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""AgNPs"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""ATCC 10145"",""NP_Synthesis"":""non-explosive high-voltage method"",""Drug"":""Streptomycin"",""Drug_dose"":""6.0"",""NP_concentration"":""0.25"",""sizes"":{""min_nm"":""2"",""max_nm"":""35"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""chequerboard"",""ZOI_drug_mm_or_Minimal_concentration"":""24"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""1"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""0.5"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""0.5"",""Effect"":""Synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""AgNPs"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""ATCC 10145"",""NP_Synthesis"":""non-explosive high-voltage method"",""Drug"":""Rifampicin"",""Drug_dose"":""4.0"",""NP_concentration"":""0.125"",""sizes"":{""min_nm"":""2"",""max_nm"":""35"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""chequerboard"",""ZOI_drug_mm_or_Minimal_concentration"":""16"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""1"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""0.375"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""0.375"",""Effect"":""Synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""AgNPs"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""ATCC 10145"",""NP_Synthesis"":""non-explosive high-voltage method"",""Drug"":""Tetracycline"",""Drug_dose"":""2.5"",""NP_concentration"":""0.25"",""sizes"":{""min_nm"":""2"",""max_nm"":""35"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""chequerboard"",""ZOI_drug_mm_or_Minimal_concentration"":""10"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""1"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""0.5"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""0.5"",""Effect"":""Synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
23_1-s2.0-S0944501315300136-main.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Ag"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""ATCC 8739"",""NP_Synthesis"":""mycosynthesis using A. terreus"",""Drug"":""Streptomycin"",""Drug_dose"":""1.0 mg/mL"",""NP_concentration"":""1.0 mg/mL"",""sizes"":{""min_nm"":""10"",""max_nm"":""50"",""avg_nm"":""NaN""},""shape"":""anisotropic"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""14.27 mm"",""error_ZOI_drug_mm_or_Minimal_concentration"":""±0.15"",""ZOI_NP_or_MC_NP"":""22.47 mm"",""error_ZOI_NP_or_MC_NP"":""±0.06"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""ATCC 27853"",""NP_Synthesis"":""mycosynthesis using A. terreus"",""Drug"":""Streptomycin"",""Drug_dose"":""1.0 mg/mL"",""NP_concentration"":""1.0 mg/mL"",""sizes"":{""min_nm"":""10"",""max_nm"":""50"",""avg_nm"":""NaN""},""shape"":""anisotropic"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""13.33 mm"",""error_ZOI_drug_mm_or_Minimal_concentration"":""±0.15"",""ZOI_NP_or_MC_NP"":""17.13 mm"",""error_ZOI_NP_or_MC_NP"":""±0.15"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Enterococcus faecalis"",""ATCC_species"":""ATCC 29212"",""NP_Synthesis"":""mycosynthesis using A. terreus"",""Drug"":""Streptomycin"",""Drug_dose"":""1.0 mg/mL"",""NP_concentration"":""1.0 mg/mL"",""sizes"":{""min_nm"":""10"",""max_nm"":""50"",""avg_nm"":""NaN""},""shape"":""anisotropic"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""17.53 mm"",""error_ZOI_drug_mm_or_Minimal_concentration"":""±0.21"",""ZOI_NP_or_MC_NP"":""19.47 mm"",""error_ZOI_NP_or_MC_NP"":""±0.06"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Bacillus subtilis"",""ATCC_species"":""ATCC 6633"",""NP_Synthesis"":""mycosynthesis using A. terreus"",""Drug"":""Streptomycin"",""Drug_dose"":""1.0 mg/mL"",""NP_concentration"":""1.0 mg/mL"",""sizes"":{""min_nm"":""10"",""max_nm"":""50"",""avg_nm"":""NaN""},""shape"":""anisotropic"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""24.37 mm"",""error_ZOI_drug_mm_or_Minimal_concentration"":""±0.23"",""ZOI_NP_or_MC_NP"":""16.43 mm"",""error_ZOI_NP_or_MC_NP"":""±0.21"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Methicillin-resistant S. aureus"",""ATCC_species"":""NaN"",""NP_Synthesis"":""mycosynthesis using A. terreus"",""Drug"":""Streptomycin"",""Drug_dose"":""1.0 mg/mL"",""NP_concentration"":""1.0 mg/mL"",""sizes"":{""min_nm"":""10"",""max_nm"":""50"",""avg_nm"":""NaN""},""shape"":""anisotropic"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""5.97 mm"",""error_ZOI_drug_mm_or_Minimal_concentration"":""±0.15"",""ZOI_NP_or_MC_NP"":""16.15 mm"",""error_ZOI_NP_or_MC_NP"":""±0.07"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""ATCC 29736"",""NP_Synthesis"":""mycosynthesis using A. terreus"",""Drug"":""Streptomycin"",""Drug_dose"":""1.0 mg/mL"",""NP_concentration"":""1.0 mg/mL"",""sizes"":{""min_nm"":""10"",""max_nm"":""50"",""avg_nm"":""NaN""},""shape"":""anisotropic"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""25.33 mm"",""error_ZOI_drug_mm_or_Minimal_concentration"":""±0.15"",""ZOI_NP_or_MC_NP"":""14.27 mm"",""error_ZOI_NP_or_MC_NP"":""±0.12"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
16_IJN-49284-combined-efficacy-of-biologically-synthesized-silver-nanopar_081913.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Ag"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""NaN"",""NP_Synthesis"":""extracellular mycosynthesis by Aspergillus flavus"",""Drug"":""Imipenem"",""Drug_dose"":""14"",""NP_concentration"":""15"",""sizes"":{""min_nm"":""5"",""max_nm"":""30"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""23"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""14.75"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""25"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""0.2-4.4"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""NaN"",""NP_Synthesis"":""extracellular mycosynthesis by Aspergillus flavus"",""Drug"":""Ciprofloxacin"",""Drug_dose"":""13"",""NP_concentration"":""15"",""sizes"":{""min_nm"":""5"",""max_nm"":""30"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""20"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""14.75"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""38"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""0.1-5.3"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Bacillus spp."",""ATCC_species"":""NaN"",""NP_Synthesis"":""extracellular mycosynthesis by Aspergillus flavus"",""Drug"":""Vancomycin"",""Drug_dose"":""4"",""NP_concentration"":""15"",""sizes"":{""min_nm"":""5"",""max_nm"":""30"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""21"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""14.75"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""19"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""0.3-7.0"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
5_habash2014.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Ag"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""PAO1"",""NP_Synthesis"":""citrate-capped"",""Drug"":""Aztreonam"",""Drug_dose"":""64.0"",""NP_concentration"":""0.625"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""10""},""shape"":""NaN"",""method"":""MBEC"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""18"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""PAO1"",""NP_Synthesis"":""citrate-capped"",""Drug"":""Aztreonam"",""Drug_dose"":""64.0"",""NP_concentration"":""0.625"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""100""},""shape"":""NaN"",""method"":""MBEC"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""no synergy"",""time_hr"":""18"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""100"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""NaN"",""NP_Synthesis"":""chemical synthesis"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""7"",""max_nm"":""70"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""NaN"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
82_processes-11-00272.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""TiO2"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Juniperus phoenicea extract"",""Drug"":""Oxytetracycline"",""Drug_dose"":""30 mg"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""23.3"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.27"",""ZOI_NP_or_MC_NP"":""40"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""TiO2"",""Bacteria"":""Bacillus subtilis"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Juniperus phoenicea extract"",""Drug"":""Oxytetracycline"",""Drug_dose"":""30 mg"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""25.5"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.31"",""ZOI_NP_or_MC_NP"":""40"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
79_10.4236@jbnb.2010.11005.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""TiO2"",""Bacteria"":""Methicillin-resistant Staphylococcus aureus"",""ATCC_species"":""NaN"",""NP_Synthesis"":""citric acid and alpha dextrose route"",""Drug"":""Penicillin G"",""Drug_dose"":""10U"",""NP_concentration"":""20 μg/disc"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""20""},""shape"":""cubic"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""34"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""44"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""10 mm"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""TiO2"",""Bacteria"":""Methicillin-resistant Staphylococcus aureus"",""ATCC_species"":""NaN"",""NP_Synthesis"":""citric acid and alpha dextrose route"",""Drug"":""Amikacin"",""Drug_dose"":""10 μg"",""NP_concentration"":""20 μg/disc"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""20""},""shape"":""cubic"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""15"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""25"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""10 mm"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
43_roshmi2015.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Au"",""Bacteria"":""Staphylococcus epidermidis"",""ATCC_species"":""73"",""NP_Synthesis"":""biosynthesis by Bacillus sp."",""Drug"":""Ciprofloxacin"",""Drug_dose"":""31.25"",""NP_concentration"":""20"",""sizes"":{""min_nm"":""12"",""max_nm"":""32"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""disk diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""35"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""37"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""0.12"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""7.81"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
38_NMRJ_Volume 5_Issue 1_Pages 44-54.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""AgNPs"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Green synthesis"",""Drug"":""Levofloxacin"",""Drug_dose"":""2"",""NP_concentration"":""16"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""2"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""16"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""0.5"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""0.281"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""AgNPs"",""Bacteria"":""Vibrio cholerae"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Green synthesis"",""Drug"":""Levofloxacin"",""Drug_dose"":""8"",""NP_concentration"":""16"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""8"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""16"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""8"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""1.5"",""Effect"":""additive"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""AgNPs"",""Bacteria"":""Enterococcus faecalis"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Green synthesis"",""Drug"":""Levofloxacin"",""Drug_dose"":""8"",""NP_concentration"":""32"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""8"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""32"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""0.25"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""0.038"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""AgNPs"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Green synthesis"",""Drug"":""Levofloxacin"",""Drug_dose"":""1"",""NP_concentration"":""4"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""1"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""4"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""0.25"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""0.312"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""AgNPs"",""Bacteria"":""Salmonella Typhi"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Green synthesis"",""Drug"":""Levofloxacin"",""Drug_dose"":""1"",""NP_concentration"":""32"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""1"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""32"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""0.25"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""0.257"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""AgNPs"",""Bacteria"":""Proteus vulgaris"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Green synthesis"",""Drug"":""Levofloxacin"",""Drug_dose"":""32"",""NP_concentration"":""16"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""32"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""16"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""16"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""1"",""Effect"":""additive"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
34_abo-shama2020.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Ag"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""KY797673"",""NP_Synthesis"":""Biosynthesis using Ulva fasciata"",""Drug"":""Azithromycin"",""Drug_dose"":""15 µg"",""NP_concentration"":""170 µg/mL"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""15""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""28.00"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.57"",""ZOI_NP_or_MC_NP"":""26.00"",""error_ZOI_NP_or_MC_NP"":""0.57"",""ZOI_drug_NP_or_MIC_drug_NP"":""41.00"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.57"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""ZnO"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""MF359584"",""NP_Synthesis"":""Biosynthesis using Ulva fasciata"",""Drug"":""Cefotaxime"",""Drug_dose"":""40 µg"",""NP_concentration"":""10 mg/mL"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""187""},""shape"":""rod-shaped"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""33.00"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.57"",""ZOI_NP_or_MC_NP"":""20.00"",""error_ZOI_NP_or_MC_NP"":""0.57"",""ZOI_drug_NP_or_MIC_drug_NP"":""35.00"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.56"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
30_s41598-022-19698-0.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Ag"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Biosynthesis using Streptomyces xinghaiensis"",""Drug"":""Ceftriaxone"",""Drug_dose"":""1024"",""NP_concentration"":""64"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""10""},""shape"":""spherical"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""1024"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""64"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""16"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""0.26"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Biosynthesis using Streptomyces xinghaiensis"",""Drug"":""Imipenem"",""Drug_dose"":""8"",""NP_concentration"":""64"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""10""},""shape"":""spherical"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""8"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""64"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""4"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""0.56"",""Effect"":""partial synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Acinetobacter baumannii"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Biosynthesis using A. baumannii strain"",""Drug"":""Ceftriaxone"",""Drug_dose"":""1024"",""NP_concentration"":""8"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""10""},""shape"":""spherical"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""1024"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""8"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""4"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""0.5"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
69_pageni2018.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""FeNP"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""ATCC 33591"",""NP_Synthesis"":""coprecipitation method with RAFT polymerization"",""Drug"":""Penicillin"",""Drug_dose"":""7 µg/mL"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""33""},""shape"":""NaN"",""method"":""disk_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""8 mm"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""18 mm"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""1.67"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""Cobaltocenium-containing polymer"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""FeNP"",""Bacteria"":""Bacillus cereus"",""ATCC_species"":""ATCC 11778"",""NP_Synthesis"":""coprecipitation method with RAFT polymerization"",""Drug"":""Penicillin"",""Drug_dose"":""7 µg/mL"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""33""},""shape"":""NaN"",""method"":""disk_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""10 mm"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""20 mm"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""2.0"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""Cobaltocenium-containing polymer"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""FeNP"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""ATCC 11775"",""NP_Synthesis"":""coprecipitation method with RAFT polymerization"",""Drug"":""Penicillin"",""Drug_dose"":""7 µg/mL"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""33""},""shape"":""NaN"",""method"":""disk_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""4 mm"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""12 mm"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""3.0"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""Cobaltocenium-containing polymer"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""FeNP"",""Bacteria"":""Proteus vulgaris"",""ATCC_species"":""ATCC 33420"",""NP_Synthesis"":""coprecipitation method with RAFT polymerization"",""Drug"":""Penicillin"",""Drug_dose"":""7 µg/mL"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""33""},""shape"":""NaN"",""method"":""disk_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""6 mm"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""12 mm"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""2.0"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""Cobaltocenium-containing polymer"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""FeNP"",""Bacteria"":""Klebsiella pneumonia"",""ATCC_species"":""ATCC 35596"",""NP_Synthesis"":""coprecipitation method with RAFT polymerization"",""Drug"":""Penicillin"",""Drug_dose"":""7 µg/mL"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""33""},""shape"":""NaN"",""method"":""disk_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""4 mm"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""12 mm"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""3.0"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""Cobaltocenium-containing polymer"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
35_10.2147@IJN.S246484.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Silver nanoparticles"",""Bacteria"":""Staphylococcus epidermidis"",""ATCC_species"":""MRSE, MLSB"",""NP_Synthesis"":""Tween 80 stabilization"",""Drug"":""Gentamicin"",""Drug_dose"":""Variable, e.g., 0.97 to 500 μg/mL"",""NP_concentration"":""21.5 to 1400 μg/mL"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""Checkerboard assay"",""ZOI_drug_mm_or_Minimal_concentration"":""Varied, see details"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""No effect alone"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""Varied, see details"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""16"",""Zeta_potential_mV"":""NaN"",""MDR"":""Gentamicin-resistant"",""FIC"":""0.08 to 0.26"",""Effect"":""Synergistic"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""None"",""combined_MIC"":""Varied, e.g., 7.81 to 62.5 μg/mL"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
37_chopade2013.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Ag"",""Bacteria"":""Acinetobacter baumannii"",""ATCC_species"":""AIIMS 7"",""NP_Synthesis"":""biosynthesis using Acinetobacter calcoaceticus"",""Drug"":""Vancomycin"",""Drug_dose"":""500 μg/disc"",""NP_concentration"":""15 μg/disc"",""sizes"":{""min_nm"":""8.0"",""max_nm"":""12.0"",""avg_nm"":""10.0""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""7.0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.6"",""ZOI_NP_or_MC_NP"":""6.0"",""error_ZOI_NP_or_MC_NP"":""0.0"",""ZOI_drug_NP_or_MIC_drug_NP"":""10.0"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""1.0"",""fold_increase_in_antibacterial_activity"":""1.8"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Enterobacter aerogenes"",""ATCC_species"":""NCIM 2964"",""NP_Synthesis"":""biosynthesis using Acinetobacter calcoaceticus"",""Drug"":""Vancomycin"",""Drug_dose"":""500 μg/disc"",""NP_concentration"":""15 μg/disc"",""sizes"":{""min_nm"":""8.0"",""max_nm"":""12.0"",""avg_nm"":""10.0""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""11.0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.2"",""ZOI_NP_or_MC_NP"":""6.0"",""error_ZOI_NP_or_MC_NP"":""0.0"",""ZOI_drug_NP_or_MIC_drug_NP"":""24.0"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""3.8"",""fold_increase_in_antibacterial_activity"":""3.8"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
39_PM-13-828.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Ag"",""Bacteria"":""Enterococcus faecalis"",""ATCC_species"":""NaN"",""NP_Synthesis"":""extracellular synthesis using Klebsiella pneumoniae"",""Drug"":""Gentamicin, Chloramphenicol"",""Drug_dose"":""10.0"",""NP_concentration"":""10.0, 20.0, 30.0"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""20.0""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""Gentamicin: 19.0; Chloramphenicol: 20.0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""10.0"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""Gentamicin + AgNPs: 21.0; Chloramphenicol + AgNPs: 22.0; Chloramphenicol + Gentamicin + AgNPs: 34.0"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""1.0"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""24.0"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
15_fmicb-13-929491.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Ag@Fe3O4"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Wet chemical reduction and modified co-precipitation"",""Drug"":""Polymyxin"",""Drug_dose"":""20 μg (per disc)"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""25""},""shape"":""Cubic core with Ag shell"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""4.5"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.25"",""ZOI_NP_or_MC_NP"":""5.4"",""error_ZOI_NP_or_MC_NP"":""0.12"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""-9"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""2.0"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""30.0"",""viability_error"":""NaN""},{""NP"":""Ag@Fe3O4"",""Bacteria"":""Salmonella typhimurium"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Wet chemical reduction and modified co-precipitation"",""Drug"":""Kanamycin"",""Drug_dose"":""30 μg (per disc)"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""25""},""shape"":""Cubic core with Ag shell"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""2.5"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0.1"",""ZOI_NP_or_MC_NP"":""3.1"",""error_ZOI_NP_or_MC_NP"":""0.2"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""-9"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""2.0"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""20.0"",""viability_error"":""NaN""}]}"
28_10.1371@journal.pone.0224904.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""AgNPs"",""Bacteria"":""S. aureus"",""ATCC_species"":""NaN"",""NP_Synthesis"":""commercially available Argovit formulation"",""Drug"":""Aztreonam"",""Drug_dose"":""16 μg/mL"",""NP_concentration"":""6 μg/mL"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""35 ± 15 nm""},""shape"":""spheroid"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""0.05 μg/mL"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""-18 ± 1.1 mV"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""No Effect"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
31_thirumurugan2016.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Ag"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""ATCC 25922"",""NP_Synthesis"":""biological synthesis using Phytophthora infestans"",""Drug"":""Cefazolin"",""Drug_dose"":""0.625"",""NP_concentration"":""5.0"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""0.625"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""5.0"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""0.6"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""0.5"",""Effect"":""Partially Synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""ATCC 25619"",""NP_Synthesis"":""biological synthesis using Phytophthora infestans"",""Drug"":""Mupirocin"",""Drug_dose"":""0.3125"",""NP_concentration"":""2.5"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""2.5"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""0.1"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""0.15"",""Effect"":""Synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""ATCC 10536"",""NP_Synthesis"":""biological synthesis using Phytophthora infestans"",""Drug"":""Gentamycin"",""Drug_dose"":""0.625"",""NP_concentration"":""2.5"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""2.5"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""0.4"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""0.16"",""Effect"":""Synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
62_azam2012.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""CuO"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""NaN"",""NP_Synthesis"":""gel combustion route"",""Drug"":""Tetracycline"",""Drug_dose"":""NaN"",""NP_concentration"":""50"",""sizes"":{""min_nm"":""20"",""max_nm"":""NaN"",""avg_nm"":""20.01""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""20"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""20"",""error_ZOI_NP_or_MC_NP"":""1.24"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""CuO"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""NaN"",""NP_Synthesis"":""gel combustion route"",""Drug"":""Tetracycline"",""Drug_dose"":""NaN"",""NP_concentration"":""50"",""sizes"":{""min_nm"":""20"",""max_nm"":""NaN"",""avg_nm"":""20.01""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""18"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""21"",""error_ZOI_NP_or_MC_NP"":""1.24"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""CuO"",""Bacteria"":""Bacillus subtilis"",""ATCC_species"":""NaN"",""NP_Synthesis"":""gel combustion route"",""Drug"":""Tetracycline"",""Drug_dose"":""NaN"",""NP_concentration"":""50"",""sizes"":{""min_nm"":""20"",""max_nm"":""NaN"",""avg_nm"":""20.01""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""20"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""24"",""error_ZOI_NP_or_MC_NP"":""1.24"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""CuO"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""NaN"",""NP_Synthesis"":""gel combustion route"",""Drug"":""Tetracycline"",""Drug_dose"":""NaN"",""NP_concentration"":""50"",""sizes"":{""min_nm"":""20"",""max_nm"":""NaN"",""avg_nm"":""20.01""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""22"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""22"",""error_ZOI_NP_or_MC_NP"":""1.24"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""CuO"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""NaN"",""NP_Synthesis"":""gel combustion route"",""Drug"":""Tetracycline"",""Drug_dose"":""NaN"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""20 ± 3"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""CuO"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""NaN"",""NP_Synthesis"":""gel combustion route"",""Drug"":""Tetracycline"",""Drug_dose"":""NaN"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""28 ± 4"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""CuO"",""Bacteria"":""Bacillus subtilis"",""ATCC_species"":""NaN"",""NP_Synthesis"":""gel combustion route"",""Drug"":""Tetracycline"",""Drug_dose"":""NaN"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""30 ± 5"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""CuO"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""NaN"",""NP_Synthesis"":""gel combustion route"",""Drug"":""Tetracycline"",""Drug_dose"":""NaN"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""25 ± 4"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
54_polymers-14-00771-v2.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""C-AuNPs"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Cefotaxime sodium as reducing and capping agent"",""Drug"":""Cefotaxime"",""Drug_dose"":""20 µg/well"",""NP_concentration"":""4.19 µg/well"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""65""},""shape"":""spherical"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""1.48 µg/mL"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""0.73 µg/mL"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""0.73 µg/mL"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""-23"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""C-AuNPs"",""Bacteria"":""Klebsiella oxytoca"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Cefotaxime sodium as reducing and capping agent"",""Drug"":""Cefotaxime"",""Drug_dose"":""20 µg/well"",""NP_concentration"":""4.19 µg/well"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""65""},""shape"":""spherical"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""3.03 µg/mL"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""1.03 µg/mL"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""1.03 µg/mL"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""-23"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""C-AuNPs"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Cefotaxime sodium as reducing and capping agent"",""Drug"":""Cefotaxime"",""Drug_dose"":""20 µg/well"",""NP_concentration"":""4.19 µg/well"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""65""},""shape"":""spherical"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""1.92 µg/mL"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""0.87 µg/mL"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""0.87 µg/mL"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""-23"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""C-AuNPs"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Cefotaxime sodium as reducing and capping agent"",""Drug"":""Cefotaxime"",""Drug_dose"":""20 µg/well"",""NP_concentration"":""4.19 µg/well"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""65""},""shape"":""spherical"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""1.34 µg/mL"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""0.68 µg/mL"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""0.68 µg/mL"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""-23"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
86_2023.08.01.34.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""TiO2"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""ATCC 25923"",""NP_Synthesis"":""Commercial"",""Drug"":""Amikacin"",""Drug_dose"":""10 mcg/disc"",""NP_concentration"":""1000 µg/ml"",""sizes"":{""min_nm"":""100"",""max_nm"":""100"",""avg_nm"":""100""},""shape"":""Nan"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""Nan"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""20-24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""TiO2"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""ATCC 25923"",""NP_Synthesis"":""Commercial"",""Drug"":""Levofloxacin"",""Drug_dose"":""5 mcg/disc"",""NP_concentration"":""500 µg/ml"",""sizes"":{""min_nm"":""100"",""max_nm"":""100"",""avg_nm"":""100""},""shape"":""Nan"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""Nan"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""20-24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
52_shamaila2016.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Gold"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Chemical reduction method"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""67.72 µg/mL"",""sizes"":{""min_nm"":""6"",""max_nm"":""40"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""2.93 µg/mL"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""31 mm"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Gold"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Chemical reduction method"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""67.72 µg/mL"",""sizes"":{""min_nm"":""6"",""max_nm"":""40"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""3.92 µg/mL"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""22 mm"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Gold"",""Bacteria"":""Bacillus subtilis"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Chemical reduction method"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""67.72 µg/mL"",""sizes"":{""min_nm"":""7"",""max_nm"":""34"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""7.56 µg/mL"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Gold"",""Bacteria"":""Klebsiella pneumonia"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Chemical reduction method"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""67.72 µg/mL"",""sizes"":{""min_nm"":""7"",""max_nm"":""34"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""3.15 µg/mL"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""NaN"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
72_10.1186@s12951-020-0588-6.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Fe3O4"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""PAO1"",""NP_Synthesis"":""chemical synthesis"",""Drug"":""Tobramycin"",""Drug_dose"":""10"",""NP_concentration"":""10"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""16""},""shape"":""NaN"",""method"":""Disk diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""23"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""23"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""Alginate"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Fe3O4@ALG"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""PAO1"",""NP_Synthesis"":""chemical synthesis"",""Drug"":""Tobramycin"",""Drug_dose"":""5"",""NP_concentration"":""5"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""Disk diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""16"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""11"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""Alginate"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""ZVFe@ALG"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""PAO1"",""NP_Synthesis"":""chemical synthesis"",""Drug"":""Tobramycin"",""Drug_dose"":""2.5"",""NP_concentration"":""2.5"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""Disk diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""20"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""7"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""Alginate"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
68_patra2016.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Fe3O4"",""Bacteria"":""Bacillus cereus"",""ATCC_species"":""ATCC 13061"",""NP_Synthesis"":""green synthesis using aqueous extract of corn ear leaves"",""Drug"":""Kanamycin"",""Drug_dose"":""5 μg/disc"",""NP_concentration"":""25 μg/disc"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""37.86""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0"",""ZOI_NP_or_MC_NP"":""0"",""error_ZOI_NP_or_MC_NP"":""0"",""ZOI_drug_NP_or_MIC_drug_NP"":""9.87"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.34"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""24.0"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Fe3O4"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""ATCC 43890"",""NP_Synthesis"":""green synthesis using aqueous extract of corn ear leaves"",""Drug"":""Kanamycin"",""Drug_dose"":""5 μg/disc"",""NP_concentration"":""25 μg/disc"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""37.86""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0"",""ZOI_NP_or_MC_NP"":""0"",""error_ZOI_NP_or_MC_NP"":""0"",""ZOI_drug_NP_or_MIC_drug_NP"":""18.86"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.82"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""24.0"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Fe3O4"",""Bacteria"":""Listeria monocytogenes"",""ATCC_species"":""ATCC 19115"",""NP_Synthesis"":""green synthesis using aqueous extract of corn ear leaves"",""Drug"":""Kanamycin"",""Drug_dose"":""5 μg/disc"",""NP_concentration"":""25 μg/disc"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""37.86""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0"",""ZOI_NP_or_MC_NP"":""0"",""error_ZOI_NP_or_MC_NP"":""0"",""ZOI_drug_NP_or_MIC_drug_NP"":""13.54"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.30"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""24.0"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Fe3O4"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""ATCC 49444"",""NP_Synthesis"":""green synthesis using aqueous extract of corn ear leaves"",""Drug"":""Kanamycin and Rifampicin"",""Drug_dose"":""5 μg/disc each"",""NP_concentration"":""25 μg/disc"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""37.86""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0"",""ZOI_NP_or_MC_NP"":""0"",""error_ZOI_NP_or_MC_NP"":""0"",""ZOI_drug_NP_or_MIC_drug_NP"":""20.90"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.50"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""24.0"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Fe3O4"",""Bacteria"":""Salmonella typhimurium"",""ATCC_species"":""ATCC 43174"",""NP_Synthesis"":""green synthesis using aqueous extract of corn ear leaves"",""Drug"":""Kanamycin"",""Drug_dose"":""5 μg/disc"",""NP_concentration"":""25 μg/disc"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""37.86""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0"",""ZOI_NP_or_MC_NP"":""0"",""error_ZOI_NP_or_MC_NP"":""0"",""ZOI_drug_NP_or_MIC_drug_NP"":""13.3"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.47"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""24.0"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Fe3O4"",""Bacteria"":""Candida albicans"",""ATCC_species"":""KACC 30003"",""NP_Synthesis"":""green synthesis using aqueous extract of corn ear leaves"",""Drug"":""Amphotericin B"",""Drug_dose"":""5 μg/disc"",""NP_concentration"":""50 μg/disc"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""37.86""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0"",""ZOI_NP_or_MC_NP"":""0"",""error_ZOI_NP_or_MC_NP"":""0"",""ZOI_drug_NP_or_MIC_drug_NP"":""9.37"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.31"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Fe3O4"",""Bacteria"":""Candida albicans"",""ATCC_species"":""KACC 30062"",""NP_Synthesis"":""green synthesis using aqueous extract of corn ear leaves"",""Drug"":""Amphotericin B"",""Drug_dose"":""5 μg/disc"",""NP_concentration"":""50 μg/disc"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""37.86""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0"",""ZOI_NP_or_MC_NP"":""0"",""error_ZOI_NP_or_MC_NP"":""0"",""ZOI_drug_NP_or_MIC_drug_NP"":""16.69"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.10"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Fe3O4"",""Bacteria"":""Candida glabrata"",""ATCC_species"":""KBNO 6P00368"",""NP_Synthesis"":""green synthesis using aqueous extract of corn ear leaves"",""Drug"":""Amphotericin B"",""Drug_dose"":""5 μg/disc"",""NP_concentration"":""50 μg/disc"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""37.86""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0"",""ZOI_NP_or_MC_NP"":""0"",""error_ZOI_NP_or_MC_NP"":""0"",""ZOI_drug_NP_or_MIC_drug_NP"":""10.39"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.37"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Fe3O4"",""Bacteria"":""Candida geochares"",""ATCC_species"":""KACC 30061"",""NP_Synthesis"":""green synthesis using aqueous extract of corn ear leaves"",""Drug"":""Amphotericin B"",""Drug_dose"":""5 μg/disc"",""NP_concentration"":""50 μg/disc"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""37.86""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0"",""ZOI_NP_or_MC_NP"":""0"",""error_ZOI_NP_or_MC_NP"":""0"",""ZOI_drug_NP_or_MIC_drug_NP"":""15.97"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.58"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Fe3O4"",""Bacteria"":""Candida saitoana"",""ATCC_species"":""KACC 41238"",""NP_Synthesis"":""green synthesis using aqueous extract of corn ear leaves"",""Drug"":""Amphotericin B"",""Drug_dose"":""5 μg/disc"",""NP_concentration"":""50 μg/disc"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""37.86""},""shape"":""NaN"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""0"",""error_ZOI_drug_mm_or_Minimal_concentration"":""0"",""ZOI_NP_or_MC_NP"":""0"",""error_ZOI_NP_or_MC_NP"":""0"",""ZOI_drug_NP_or_MIC_drug_NP"":""10.59"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""0.18"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
83_10.1016@j.sajb.2019.05.024.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""TiO2"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""PGIMER"",""NP_Synthesis"":""Green synthesis using Azadirachta indica"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""66"",""sizes"":{""min_nm"":""15"",""max_nm"":""50"",""avg_nm"":""33""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""21.33"",""error_ZOI_NP_or_MC_NP"":""1.45"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""TiO2"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""PGIMER"",""NP_Synthesis"":""Green synthesis using Azadirachta indica"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""66"",""sizes"":{""min_nm"":""15"",""max_nm"":""50"",""avg_nm"":""33""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""18"",""error_ZOI_NP_or_MC_NP"":""1.15"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""TiO2"",""Bacteria"":""Bacillus subtilis"",""ATCC_species"":""PGIMER"",""NP_Synthesis"":""Green synthesis using Azadirachta indica"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""66"",""sizes"":{""min_nm"":""15"",""max_nm"":""50"",""avg_nm"":""33""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""14.67"",""error_ZOI_NP_or_MC_NP"":""2.03"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""TiO2"",""Bacteria"":""Salmonella typhi"",""ATCC_species"":""PGIMER"",""NP_Synthesis"":""Green synthesis using Azadirachta indica"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""66"",""sizes"":{""min_nm"":""15"",""max_nm"":""50"",""avg_nm"":""33""},""shape"":""spherical"",""method"":""disc_diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""14"",""error_ZOI_NP_or_MC_NP"":""1.53"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
56_li2016.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""AuNPs"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""ATCC 25922"",""NP_Synthesis"":""Biosynthesis by Deinococcus radiodurans"",""Drug"":""Chloramphenicol"",""Drug_dose"":""6 μg/disc"",""NP_concentration"":""80 μg/disc"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""43.75""},""shape"":""spherical and irregular shapes"",""method"":""disk diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""9.21"",""error_ZOI_NP_or_MC_NP"":""0.20"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""AuNPs"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""ATCC 6538"",""NP_Synthesis"":""Biosynthesis by Deinococcus radiodurans"",""Drug"":""Chloramphenicol"",""Drug_dose"":""6 μg/disc"",""NP_concentration"":""80 μg/disc"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""43.75""},""shape"":""spherical and irregular shapes"",""method"":""disk diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""8.95"",""error_ZOI_NP_or_MC_NP"":""0.17"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""AuNPs"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""DH5α"",""NP_Synthesis"":""Biosynthesis by Deinococcus radiodurans"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""150 μg/mL"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""standard dilution micromethod"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""74.15% inhibition"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""AuNPs"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Biosynthesis by Deinococcus radiodurans"",""Drug"":""NaN"",""Drug_dose"":""NaN"",""NP_concentration"":""150 μg/mL"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""standard dilution micromethod"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""44.76% inhibition"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
75_d1ra04390k.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Fe3O4/DOPA/Van"",""Bacteria"":""Bacillus subtilis"",""ATCC_species"":""ATCC 6633"",""NP_Synthesis"":""Co-precipitation and ligand exchange with oleic acid and dopamine"",""Drug"":""Vancomycin"",""Drug_dose"":""0.002 mg/mL"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""Disc diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""22 mm"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""23 mm"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Fe3O4/DOPA/Van"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""ATCC 35218"",""NP_Synthesis"":""Co-precipitation and ligand exchange with oleic acid and dopamine"",""Drug"":""Vancomycin"",""Drug_dose"":""0.002 mg/mL"",""NP_concentration"":""NaN"",""sizes"":{""min_nm"":""NaN"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""NaN"",""method"":""Disc diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""18 mm"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""NaN"",""Zeta_potential_mV"":""NaN"",""MDR"":""NaN"",""FIC"":""NaN"",""Effect"":""NaN"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
36_chopade2012.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""Ag"",""Bacteria"":""Pseudomonas aeruginosa"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Green synthesis using D. bulbifera tuber extract"",""Drug"":""Chloramphenicol"",""Drug_dose"":""500 µg"",""NP_concentration"":""30 µg/disc"",""sizes"":{""min_nm"":""20"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""Disc diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""7"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""10"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""17"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""4.9"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Acinetobacter baumannii"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Green synthesis using D. bulbifera tuber extract"",""Drug"":""Vancomycin"",""Drug_dose"":""500 µg"",""NP_concentration"":""30 µg/disc"",""sizes"":{""min_nm"":""10"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""Disc diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""7"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""13"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""22"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""3.6"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""},{""NP"":""Ag"",""Bacteria"":""Escherichia coli"",""ATCC_species"":""NaN"",""NP_Synthesis"":""Green synthesis using D. bulbifera tuber extract"",""Drug"":""Ampicillin"",""Drug_dose"":""500 µg"",""NP_concentration"":""30 µg/disc"",""sizes"":{""min_nm"":""10"",""max_nm"":""NaN"",""avg_nm"":""NaN""},""shape"":""spherical"",""method"":""Disc diffusion"",""ZOI_drug_mm_or_Minimal_concentration"":""7"",""error_ZOI_drug_mm_or_Minimal_concentration"":""NaN"",""ZOI_NP_or_MC_NP"":""13"",""error_ZOI_NP_or_MC_NP"":""NaN"",""ZOI_drug_NP_or_MIC_drug_NP"":""22"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""NaN"",""fold_increase_in_antibacterial_activity"":""11.8"",""Zeta_potential_mV"":""NaN"",""MDR"":""R"",""FIC"":""NaN"",""Effect"":""synergistic"",""time_hr"":""NaN"",""Coating_with_antimicrobial_peptide_polymers"":""NaN"",""combined_MIC"":""NaN"",""peptide_MIC"":""NaN"",""viability"":""NaN"",""viability_error"":""NaN""}]}"
61_10.3390@molecules24173055.pdf,You are a PDF retrieval assistant.,"You are a helpful assistant in chemistry, specializing in antimicrobial drug nanoparticle synergy.","Your task is to efficiently analyze the content of the provided article PDF and extract nanoparticle properties, bacterial types, nanoparticle toxicity, drug toxicity and combined nanoparticle and drug toxicity including both MICs and ZOIs values, from various research articles assessed through various assays against different bacterial strains. Each article may contain multiple experiments varying by nanoparticle type, bacterial types, size, shape, assay type, or concentration. For each experiment extract the following information:

1. NP: Nanoparticle name (e.g., ""Ag"", ""Au"", ""CuO""). 
2. Bacteria: Bacterial strain tested (e.g., ""Escherichia coli""). 
3. ATCC Species: Strain identifier (e.g., ""MTCC 443"", ""ATCC 25922""). 
4. NP Synthesis: Synthesis method (e.g., ""chemical synthesis"", ""green synthesis""). 
5. Drug: Name of the antibiotic/drug used in combination (e.g., ""Ampicillin""). 
6. Drug Dose: Dosage/concentration of the drug (in appropriate units, typically μg/mL, μg per disc). 
7. NP_concentration: Concentration of the nanoparticle tested (required for ZOI, in μg/mL, calculated by disc_diffusion, well_diffusion, etc.). 
8. Sizes: Nanoparticle size in nm. 
8.1. Min Size (nm): Minimum size in nm (NP_size_min_nm). 
8.2. Max Size (nm): Maximum size in nm (NP_size_max_nm). 
8.3. Average Size (nm): Average size in nm (NP_size_avg_nm). 
9. Shape: Morphology (e.g., ""spherical"", ""rod-shaped""). 
10. Method: Assay type (e.g., ""MIC"", ""disc_diffusion"", ""well_diffusion""). 
11. Drug ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug alone.
12. Error Drug ZOI or MIC: Error/standard deviation for drug-only measurement. 
13. NP ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the nanoparticle alone. 
14. Error NP ZOI or MIC: Error/standard deviation for NP-only measurement. 
15. ZOI or MIC: Zone of Inhibition (mm) or MIC (μg/mL) for the drug + NP combination. 
16. Error ZOI or MIC: Error/standard deviation for the combination. 
17. Fold Increase in Antibacterial Activity: Enhancement in activity due to synergy (fold change). 
18. Zeta potential (mV): Surface charge of the nanoparticle in mV. 
19. MDR: Multidrug-resistant strain indicator (e.g., ""R"" for Resistant). 
20. FIC: Fractional Inhibitory Concentration index value. 
21. Effect: Interaction type (e.g., ""synergistic"", ""additive""). 
22. Time (hr): Duration of exposure in hours. 
23. Coating with Antimicrobial Peptide Polymers: Surface modification with antimicrobial peptides/polymers (if any). 
24. Combined MIC: Combined MIC of antimicrobial peptides/polymers and NP in μg/mL. 
25. Peptide MIC: MIC of any antimicrobial peptide used in μg/mL. 
26. Viability: Bacterial viability post-treatment in %. 
27. Viability Error: Error/standard deviation for viability. 
Additional Instructions:
1. Units: Maintain consistency with column names (e.g., nm for sizes, μg/mL for MIC or concentrations, mm for ZOI, hours for time). Do not convert units unless specified.
2. Ambiguous Data: If multiple values are reported (e.g., sizes), prioritize TEM-measured sizes or use ""Nan"" if unclear. For ZOI or MIC fields, distinguish based on method (e.g., ""MIC"" for MIC values, ""disc_diffusion"" for ZOI).
3. Chemical Names: Extract Drug, NP, Coating_with_antimicrobial_peptide_polymers, and NP_Synthesis as strings in lists (e.g., [""Ampicillin""]) without parsing into components.
4. Error Handling: Prioritize table data over text; note assumptions for ambiguous data.
5. Synergy Metrics: Ensure FIC and fold_increase_in_antibacterial_activity are extracted accurately, reflecting nanoparticle-drug interactions.
If the article references multiple samples or variations of compounds tested, ensure to extract and compile each unique set of 'NP', 'Bacteria', 'ATCC_species', 'NP_Synthesis', 'Drug', 'Drug_dose', 'NP_concentration', 'NP_size_min_nm', 'NP_size_max_nm', 'NP_size_avg_nm', 'shape', 'method', 'ZOI_drug_mm_or_Minimal_concentration', 'error_ZOI_drug_mm_or_Minimal_concentration', 'ZOI_NP_or_MC_NP', 'error_ZOI_NP_or_MC_NP', 'ZOI_drug_NP_or_MIC_drug_NP', 'error_ZOI_drug_NP_or_MIC_drug_NP', 'fold_increase_in_antibacterial_activity', 'Zeta_potential_mV', 'MDR', 'FIC', 'Effect', 'time_hr', 'Coating_with_antimicrobial_peptide_polymers', 'combined_MIC', 'peptide_MIC', 'viability', 'viability_error', information. Make sure to maintain the association between each nanoparticle, drug, and their properties.
Your output should be in JSON format  and should not contain any explanatory text. Here is the example:
```json
[
  {
    ""NP"": ""Ag"",
    ""Bacteria"": ""Pseudomonas aeruginosa"",
    ""ATCC_species"": ""ATCC 27853"",
    ""NP_Synthesis"": ""Green synthesis using Gloeophyllum striatum"",
    ""Drug"": ""Ampicillin"",
    ""Drug_dose"": ""16.0"",
    ""NP_concentration"": ""32.0"",
    ""sizes"": {""min_nm"": 10.0, ""max_nm"": 40.0, ""avg_nm"": 20.0},
    ""shape"": ""spherical"",
    ""method"": ""MIC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""16.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""1.40"",
    ""ZOI_NP_or_MC_NP"": ""32.0"",
    ""error_ZOI_NP_or_MC_NP"":  ""2.43"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""8.0"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"":  ""1.50"",
    ""fold_increase_in_antibacterial_activity"": ""2.0"",
    ""Zeta_potential_mV"": ""-34.0"",
    ""MDR"": ""R"",
    ""FIC"": ""0.5"",
    ""Effect"": ""synergistic"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""AP Lysozyme hen egg-white"",
    ""combined_MIC"": ""12"",
    ""peptide_MIC"": ""400"",
    ""viability"": ""87.0"",
    ""viability_error"": ""2.40"",
  },
  {
    ""NP"": ""Au"",
    ""Bacteria"": ""Escherichia coli"",
    ""ATCC_species"": ""BJ915"",
    ""NP_Synthesis"": ""purchased from Jinke Chemical Co"",
    ""Drug"": ""Colistin"",
    ""Drug_dose"": ""10.0"",
    ""NP_concentration"": ""25.0"",
    ""sizes"": {""min_nm"": 2.1, ""max_nm"": 2.9, ""avg_nm"": 2.5},
    ""shape"": ""cubic"",
    ""method"": ""MBC"",
    ""ZOI_drug_mm_or_Minimal_concentration"": ""4.0"",
    ""error_ZOI_drug_mm_or_Minimal_concentration"": ""0.30"",
    ""ZOI_NP_or_MC_NP"": ""12.50"",
    ""error_ZOI_NP_or_MC_NP"": ""0.87"",
    ""ZOI_drug_NP_or_MIC_drug_NP"": ""6.25"",
    ""error_ZOI_drug_NP_or_MIC_drug_NP"": ""0.27"",
    ""fold_increase_in_antibacterial_activity"": ""1.16"",
    ""Zeta_potential_mV"": "" "",
    ""MDR"": ""R"",
    ""FIC"": ""0.75"",
    ""Effect"": ""P"",
    ""time_hr"": ""24.0"",
    ""Coating_with_antimicrobial_peptide_polymers"": ""4,6-diamino-2-pyrimidinethiol + 1,1-dimethylbiguanide"",
    ""combined_MIC"": ""4.0"",
    ""peptide_MIC"": ""13.20"",
    ""viability"": ""23.0"",
    ""viability_error"": ""2.25""
  }
]
```
Do not skip any entries. If multiple viabilities are reported for the same compound against different cell lines, list them as separate entries. It is imperative that you should not make up any additional information or take the information you already know. If you did not find the parameter in the text, write 'NaN'.
","{""samples"":[{""NP"":""CuO"",""Bacteria"":""Proteus mirabilis"",""ATCC_species"":""Nan"",""NP_Synthesis"":""Green synthesis using Tamarindus indica fruit extract"",""Drug"":""Amoxyclav"",""Drug_dose"":""70 μg/mL"",""NP_concentration"":""30 μg/mL"",""sizes"":{""min_nm"":""Nan"",""max_nm"":""Nan"",""avg_nm"":""Nan""},""shape"":""Cubic"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""70"",""error_ZOI_drug_mm_or_Minimal_concentration"":""Nan"",""ZOI_NP_or_MC_NP"":""30"",""error_ZOI_NP_or_MC_NP"":""Nan"",""ZOI_drug_NP_or_MIC_drug_NP"":""4.4"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""Nan"",""fold_increase_in_antibacterial_activity"":""15.9"",""Zeta_potential_mV"":""Nan"",""MDR"":""Nan"",""FIC"":""0.062"",""Effect"":""Synergistic"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""Nan"",""combined_MIC"":""Nan"",""peptide_MIC"":""Nan"",""viability"":""Nan"",""viability_error"":""Nan""},{""NP"":""CuO"",""Bacteria"":""Staphylococcus aureus"",""ATCC_species"":""Nan"",""NP_Synthesis"":""Green synthesis using Tamarindus indica fruit extract"",""Drug"":""Amoxyclav"",""Drug_dose"":""50 μg/mL"",""NP_concentration"":""20 μg/mL"",""sizes"":{""min_nm"":""Nan"",""max_nm"":""Nan"",""avg_nm"":""Nan""},""shape"":""Cubic"",""method"":""MIC"",""ZOI_drug_mm_or_Minimal_concentration"":""50"",""error_ZOI_drug_mm_or_Minimal_concentration"":""Nan"",""ZOI_NP_or_MC_NP"":""20"",""error_ZOI_NP_or_MC_NP"":""Nan"",""ZOI_drug_NP_or_MIC_drug_NP"":""1.56"",""error_ZOI_drug_NP_or_MIC_drug_NP"":""Nan"",""fold_increase_in_antibacterial_activity"":""32"",""Zeta_potential_mV"":""Nan"",""MDR"":""Nan"",""FIC"":""0.03"",""Effect"":""Synergistic"",""time_hr"":""24"",""Coating_with_antimicrobial_peptide_polymers"":""Nan"",""combined_MIC"":""Nan"",""peptide_MIC"":""Nan"",""viability"":""Nan"",""viability_error"":""Nan""}]}"
